DHS-AFFORDABLE GENERIC DRUGS

Summary

The bill directs the Department of Human Services to form partnerships with FDA‑registered drug makers to increase competition, lower prices, and address shortages of generic medicines. It targets public and private purchasers, taxpayers, patients, pharmacies and health‑care providers by making a list of the 100 most common generics available at transparent, rebate‑free prices. The measure aims to reduce drug costs and improve access, with most provisions effective now and some kicking in on Jan. 1, 2029.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share